Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3233294
Max Phase: Preclinical
Molecular Formula: C21H34N2O4
Molecular Weight: 378.51
Molecule Type: Small molecule
Associated Items:
ID: ALA3233294
Max Phase: Preclinical
Molecular Formula: C21H34N2O4
Molecular Weight: 378.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CNCCN3CCOCC3)[C@@H]2CC1
Standard InChI: InChI=1S/C21H34N2O4/c1-15-4-3-7-21(2)19(27-21)18-16(6-5-15)17(20(24)26-18)14-22-8-9-23-10-12-25-13-11-23/h4,16-19,22H,3,5-14H2,1-2H3/b15-4+/t16-,17-,18-,19+,21+/m0/s1
Standard InChI Key: YUAZARCKMNPDNU-CYJRCRLRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 378.51 | Molecular Weight (Monoisotopic): 378.2519 | AlogP: 1.74 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.33 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.53 | CX LogP: 1.77 | CX LogD: -0.33 |
Aromatic Rings: 0 | Heavy Atoms: 27 | QED Weighted: 0.34 | Np Likeness Score: 1.55 |
1. Janganati V, Penthala NR, Cragle CE, MacNicol AM, Crooks PA.. (2014) Heterocyclic aminoparthenolide derivatives modulate G(2)-M cell cycle progression during Xenopus oocyte maturation., 24 (8): [PMID:24656611] [10.1016/j.bmcl.2014.02.067] |
Source(1):